Prefilled Syringes Market

SKU: DMMD692 | Last Updated On: Oct 01 2022 | Available Formats

> Prefilled Syringes Market Expected to reach a high CAGR 11.73% By 2029

Prefilled Syringes Market is segmented By Material (Glass-based, Plastic-based), By Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, Customized Prefilled Syringes), By Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029.

Prefilled Syringes Market Size, Share, Growth Report 2022-2029

[150 Pages Report] Prefilled Syringes Market is expected to grow at a CAGR 11.73%  during the forecast period (2022-2029). A prefilled syringe is a single-dose packet of vaccines to which a needle has been fixed by the manufacturer. Prefilled syringes are being used to deliver drug categories such as vaccines, therapeutic proteins, blood stimulants, erythropoietin, and more. In the past, metal or glass syringes were popular, but increasingly there has been a movement toward plastic and disposable syringes so the needle is protected and cannot be reused (prefilled disposable systems). This has stimulated the demand for convenient and safe prefilled syringes in the medical field over conventional glass vials for packing parental drugs.

Prefilled Syringes Market - Strategic Insights

Metrics

Details

Market CAGR

11.73%

Segments Covered

By Material, By Design, By Application, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To Get a Free Sample Click here

Market Dynamics

The global prefilled syringes market growth is driven by technological advancements, the high prevalence of chronic diseases and disorders, and the growing adoption of self-injection devices. One of the primary reasons for the rapid growth of prefilled syringe technology is its suitability for home use, a prevalent healthcare trend that provides the benefit of convenience for regular patients. 

The rising target disease population is driving the market growth  in the forecast period

Prefilled syringes are mainly used for the treatment of chronic conditions, such as heart diseases, diabetes, and autoimmune diseases, which require patients to self-administer medications. As a result, the increasing incidence and prevalence of chronic and lifestyle diseases across the globe is a major factor contributing to the growth of the prefilled syringes market. Moreover, there is a growing demand for self-injection devices, considering the convenience and safety associated with their use. In addition, pharmaceutical companies can get benefit by saving on the cost of vials. The prefilled syringes work well with safety devices and auto-injection systems. Pharmaceutical companies are able to minimize drug waste and increase product life span, while patients are able to self-administer injectable drugs at their homes instead of the hospital. Pre-filled syringes have also been utilized across a wide range of therapeutic sectors, such as vaccines, blood stimulants, and therapeutic proteins.

Eliminating dosing errors and ease of use are two of the greatest advantages of pre-filled syringes. Consequently, the differential advantages provided by prefilled syringes over traditional syringes are leading to increased adoption and contributing to the global market growth.

The dearth of prefilled syringes with integrated safety features will hamper the market growth

Prefilled syringes provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medication from vials. However, a significant number of needle stick injuries are associated with the use of bare prefilled syringes as compared to the ones that have integrated safety systems. As of 2019, there are 500,000 injuries occur in the US annually, and half of those (nearly 1,000 per day) occur in hospitals. Furthermore, as of 2019, there are 1,000,000 injuries occurring annually in Europe. In such cases, the contaminated needle of prefilled syringes can lead to blood-borne infections, such as HIV and HCV.

COVID-19 Impact Analysis

The pandemic of covid-19 has had a major impact on the market. Various market players are attempting to contribute to the vaccine shot by introducing COVID-19 vaccine-specific products to the market. For instance, Becton Dickson and Company (BD) has demonstrated that its glass prefilled syringes are suitable for use with mRNA shots that must be stored at ultralow temperatures in order to unlock a new COVID-19 vaccine opportunity. In 2020, as the storage requirements for mRNA vaccines against the coronavirus became clear, BD began looking into how its syringes handled temperatures as low as minus 20 degrees Celsius and as low as minus 40 degrees Celsius.

Segment Analysis

The diabetes segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)   

The rising prevalence of diabetes around the world is a primary factor driving market expansion. Diabetes is one of the world's most serious public health problems, posing a significant threat to public health and socioeconomic development. Although the incidence of diabetes has begun to decline in some nations, the prevalence of diabetes has climbed in most other industrialized and developing countries in recent decades. According to the Centers for Disease Control’s (CDC) National Diabetes Statistics Report for 2020 cases of diabetes have risen to an estimated 34.2 million. Also, according to the International Diabetes Federation (IDF), in 2021, around 537 million adults between 20 years & 79 years of age were living with diabetes. As per the same soured, the number of people living with diabetes is projected to increase to 63 million by 2030 and 783 million by 2045.

As per the article published in September 2020 titled “Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 202”, the prevalence of both type 1 and type 2 diabetes among children and adolescents has also increased, and the estimates of children and adolescents below age 20 with type 1 diabetes now exceed one million. In November 2020, Medtronic plc launched InPen integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily injections (MDI). Hence, all the above-mentioned factors boost the market growth.

Geographical Analysis

North America region holdsthe largest market share of the global Prefilled Syringes market

North America has the largest market share in the forecast period. In January 2017, the United States Food and Drug Administration (FDA) released final guidance describing and explaining the current good manufacturing practice (CGMP) requirements for combination products, first released in January 2013. Prefilled drug delivery systems, including prefilled syringes, are combination products subject to the Final Rule. From a manufactures perspective, the Final Rule, as provided by the US FDA, tightens the regulations for syringe manufacturers and has made the manufacturing operation more stringent than before. This has acted as a deterrent to global players based in the United States and prevents them from expanding their regional operations, in other regions.

There is a large concentration of vendors supplying both end products and original components in the prefilled syringe market. The use of prefilled syringes in the United States is consequently ensured by the presence of appropriate vendors. Lifestyle-associated illnesses and growing demand for easy-to-administer injectable in patients with chronic disease are helping the United States prefilled syringe market flourishes. Hence, market players are launching various products to treat allergic reactions. For instance, in January 2019, Sandoz Inc., a division of Novartis announced the launch of SYMJEPI (epinephrine) 0.3 mg Injection in the United States market for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.  

Competitive Landscape

Prefilled syringes market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Becton, Dickinson and Company, B. Braun Melsungen AG​, Baxter International Inc., Terumo Corporation​, Cardinal Health Inc.​, Teva Pharmaceuticals Industries Ltd​, Fresenius SE & Co. KGaA​, Mylan NV, Sanofi SA​, Syntegon Technology GmbH among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of prefilled syringes market globally. For instance, in January 2021, Aurobindo Pharma Limited announced that it has received approval from the United States Food and Drug Administration (USFDA) to manufacture and market Naloxone HCl Injection Prefilled Syringe 2 mg/2 mL.

Becton, Dickinson, and Company

Overview:

Becton, Dickinson, and Company (BD) is a global medical technology company engaged in the development, manufacture, and sale of a range of medical supplies, devices, laboratory equipment, and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences, and BD Interventional.   

Product Portfolio:

BD PosiFlush Pre-Filled Heparin Lock Flush Syringe: BD PosiFlush Pre-Filled Heparin Lock Flush Syringe is available in two concentrations, 10 USP units per mL and 100 USP units per mL—and in a variety of sizes and fill volumes to help support your catheter maintenance practice. It may help maintain catheter patency by locking vascular access devices when used in accordance with your institution’s access maintenance protocol.

Frequently Asked Questions

What is the Projected CAGR value of the Prefilled Syringes Market?

Prefilled Syringes Market is expected to grow at a CAGR of 11.73% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls the Prefilled Syringes Market during 2022-2029

Which is the fastest growing region in the Prefilled Syringes Market?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period 

Trending Topics

Safety Syringes Market

Syringes and Needles Market

Safety Syringes Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest